All In MedTech

FDA Clearance Tracker · K060875

ABBOTT AXSYM TROPONIN-I ADV

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 21, 2026Latest source record: Jun 14, 2006 (this decision)Source: openFDAMethods & limitations

510(k)

The decision

FDA number
K060875
Device name
ABBOTT AXSYM TROPONIN-I ADV
Applicant location
Abbott Park, IL
Received
Mar 30, 2006
Decided
Jun 14, 2006
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 862.1215

Every decision under product code MMI

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code MMI. The earliest in FDA's data is K924392, decided Apr 26, 1994.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

  • FDA database record for K060875
  • The applicant filed a summary instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Abbott Laboratories

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.